购物车
全部删除
您的购物车当前为空
Anti-MRSA agent 32 (Compound 26) 是一种选择性激活剂,具备口服活性,针对SaClpP (Staphylococcus aureus ClpP蛋白酶) 的EC50值为0.98 μM。通过激活SaClpP蛋白酶,它能异常降解细菌蛋白,从而抑制Staphylococcus aureus的增殖。在小鼠皮肤感染模型中,Anti-MRSA agent 32 促进伤口愈合,显示出在耐甲氧西林Staphylococcus aureus (MRSA) 等感染性疾病研究中的潜力。
Anti-MRSA agent 32 (Compound 26) 是一种选择性激活剂,具备口服活性,针对SaClpP (Staphylococcus aureus ClpP蛋白酶) 的EC50值为0.98 μM。通过激活SaClpP蛋白酶,它能异常降解细菌蛋白,从而抑制Staphylococcus aureus的增殖。在小鼠皮肤感染模型中,Anti-MRSA agent 32 促进伤口愈合,显示出在耐甲氧西林Staphylococcus aureus (MRSA) 等感染性疾病研究中的潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Anti-MRSA agent 32 相关产品
| 产品描述 | Anti-MRSA agent 32 (Compound 26) is an orally active selective activator of the Staphylococcus aureus ClpP protease (SaClpP) with an EC50 of 0.98 μM. By activating the SaClpP protease, it causes the abnormal degradation of bacterial proteins and inhibits the proliferation of Staphylococcus aureus. In a mouse skin infection model, Anti-MRSA agent 32 promotes wound healing. This compound holds potential for research in methicillin-resistant Staphylococcus aureus (MRSA) and other infectious diseases. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容